Pharma Journalist 8906 posts 0 comments

Incyte announced that the U.S. Food and Drug Administration (FDA) has approved Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment…
Read More...

Recently, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (Sanyou) and Shanghai KangaBio Co., Ltd. (KangaBio) have reached an antibody drug licensing agreement, regarding a proprietary…
Read More...

Bota Bio, a global industrial biotechnology company advancing sustainable biomanufacturing, and Medichem, a vertically integrated pharmaceutical company engaged in the process…
Read More...

Aclaris Therapeutics, Inc. announced a non-exclusive patent license agreement with Eli Lilly and Company (Lilly). Under the license agreement, Aclaris granted Lilly non-exclusive…
Read More...

Novartis announced its intention to separate Sandoz, its generics and biosimilars division into a new publicly traded standalone company, by way of a 100% spin-off. The spin-off aims…
Read More...

ElevateBio, LLC (ElevateBio) and the University of Pittsburgh announced that they have entered into a long-term strategic partnership to accelerate the development of highly innovative…
Read More...

Sonde Health has signed a multi-year agreement with Koye Pharmaceuticals, a specialty pharma organization focused on the Indian Pharmaceutical market, to develop a new vocal biomarker…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA (ibrutinib) for the treatment of…
Read More...

BioMarin Pharmaceutical Inc. announced that the European Commission (EC) has granted conditional marketing authorization (CMA) to ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for…
Read More...

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, announced that it…
Read More...